Correlation Between ZyVersa Therapeutics and Entera Bio
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Entera Bio, you can compare the effects of market volatilities on ZyVersa Therapeutics and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Entera Bio.
Diversification Opportunities for ZyVersa Therapeutics and Entera Bio
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between ZyVersa and Entera is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Entera Bio go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Entera Bio
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Entera Bio. In addition to that, ZyVersa Therapeutics is 1.48 times more volatile than Entera Bio. It trades about -0.09 of its total potential returns per unit of risk. Entera Bio is currently generating about 0.06 per unit of volatility. If you would invest 95.00 in Entera Bio on November 9, 2024 and sell it today you would earn a total of 157.00 from holding Entera Bio or generate 165.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Entera Bio
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Entera Bio |
ZyVersa Therapeutics and Entera Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Entera Bio
The main advantage of trading using opposite ZyVersa Therapeutics and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |